Lyra Therapeutics, Inc. Common Stock

LYRA US55234L1052

💰
Capitalization
Small-cap

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

🔗
Website
https://lyratherapeutics.com
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
3
🙍
Insiders
3
Person Price Shares Total Published Completed
Palasis Maria
CEO 		8.91
USD 		1,565
Sold 		13,944
USD 		10/07/2025 10/07/2025
Cavalier Jason
CFO 		8.91
USD 		684
Sold 		6,094
USD 		10/07/2025 10/07/2025
Waksal Harlan
EX OFF 		2.96
USD 		25,000
Bought 		74,095
USD 		10/11/2023 10/11/2023
Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Lyra Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Last 52W Low 52W High All-Time Low All-Time High β
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Waksal Harlan 1 74,095.00 74,095.00 10/11/2023 10/11/2023
Palasis Maria 1 13,944.15 13,944.15 10/07/2025 10/07/2025
Cavalier Jason 1 6,094.44 6,094.44 10/07/2025 10/07/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.